WallStreetZenWallStreetZen

NASDAQ: CALT
Calliditas Therapeutics Ab Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CALT

Based on 1 analyst offering 12 month price targets for Calliditas Therapeutics Ab.
Min Forecast
$50.00+166.81%
Avg Forecast
$50.00+166.81%
Max Forecast
$50.00+166.81%

Should I buy or sell CALT stock?

Based on 1 analyst offering ratings for Calliditas Therapeutics Ab.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CALT stock forecasts and price targets.

CALT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-22

1 of 1

Forecast return on equity

Is CALT forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.72%

Forecast return on assets

Is CALT forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CALT revenue forecast

What is CALT's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$185.2M+74.91%
Avg 2 year Forecast
$342.4M+223.37%
Avg 3 year Forecast
$477.3M+350.84%
CALT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CALT revenue growth forecast

How is CALT forecast to perform vs Biotechnology companies and vs the US market?
Company
65.98%
Industry
38.32%
Market
10.27%
CALT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CALT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CALT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CALT$18.74$50.00+166.81%Buy
OABI$4.78$9.00+88.28%Strong Buy
KRRO$69.30$126.25+82.18%Strong Buy
VERV$6.74$37.50+456.38%Strong Buy
GHRS$10.99$39.50+259.42%Buy
View Top Biotech Stocks

Calliditas Therapeutics Ab Stock Forecast FAQ

Is Calliditas Therapeutics Ab Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CALT) stock is to Buy CALT stock.

Out of 1 analyst, 0 (0%) are recommending CALT as a Strong Buy, 1 (100%) are recommending CALT as a Buy, 0 (0%) are recommending CALT as a Hold, 0 (0%) are recommending CALT as a Sell, and 0 (0%) are recommending CALT as a Strong Sell.

If you're new to stock investing, here's how to buy Calliditas Therapeutics Ab stock.

What is CALT's revenue growth forecast for 2024-2026?

(NASDAQ: CALT) Calliditas Therapeutics Ab's forecast annual revenue growth rate of 65.98% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Calliditas Therapeutics Ab's revenue in 2024 is $105,199,725.On average, 3 Wall Street analysts forecast CALT's revenue for 2024 to be $11,033,815,052, with the lowest CALT revenue forecast at $10,619,554,707, and the highest CALT revenue forecast at $11,365,497,396. On average, 3 Wall Street analysts forecast CALT's revenue for 2025 to be $20,399,030,187, with the lowest CALT revenue forecast at $16,322,560,635, and the highest CALT revenue forecast at $26,394,574,342.

In 2026, CALT is forecast to generate $28,439,958,729 in revenue, with the lowest revenue forecast at $24,568,444,675 and the highest revenue forecast at $32,546,814,125.

What is CALT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CALT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CALT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CALT price target, the average CALT price target is $50.00, with the highest CALT stock price forecast at $50.00 and the lowest CALT stock price forecast at $50.00.

The Wall Street analyst predicted that Calliditas Therapeutics Ab's share price could reach $50.00 by Feb 22, 2025. The average Calliditas Therapeutics Ab stock price prediction forecasts a potential upside of 166.81% from the current CALT share price of $18.74.

What is CALT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CALT) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.